chevron_leftBack
As of 24 April 2025, Hanmi Science Co., Ltd. has a market cap of $1.34B USD, ranking #6880 globally and #149 in South Korea. It ranks #660 in the Healthcare sector, and #22 in the Medical Distribution industry.
Key Stats
Market Cap
$1.34BUSD
1.92T KRW
Enterprise Value
$1.44BUSD
2.05T KRW
Revenue (TTM)
$899.11MUSD
1.28T KRW
EBITDA (TTM)
$33.39MUSD
47.67B KRW
Net Income (TTM)
$41.63MUSD
59.42B KRW
EBITDA Margin
3.7%
Profit Margin
4.6%
PE Ratio
32.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Jong-Hoon Lim
open_in_new
Employees
444
Founded
1973
Website
hanmiscience.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | 0.2% | -1.4% | -2.9% | -21% | -13% |
Upcoming Earnings
Earnings Date
Wed, Apr 30
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
008930
한미사이언스(주)
ISIN: KR7008930000
Shares Out.:
Shares Outstanding:
67.714M1
Shares Float:
17.365M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
28.0K KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Hanmi Science Co., Ltd.
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult’s bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.
